Form 8-K - Current report:
SEC Accession No. 0001628280-15-001468
Filing Date
2015-03-04
Accepted
2015-03-04 17:26:17
Documents
3
Period of Report
2015-03-03
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 8-K - Q4 2014 EARNINGS RELEASE a2014q4-earningsrelease.htm 8-K 28056
2 EXHIBIT 99.1 EARNINGS RELEASE a2014q4exhibit991earningsr.htm EX-99.1 364248
3 cumberlandpharmalogoa01.jpg GRAPHIC 37721
  Complete submission text file 0001628280-15-001468.txt   445460
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: 8-K | Act: 34 | File No.: 001-33637 | Film No.: 15674515
SIC: 2834 Pharmaceutical Preparations